Published in Medical Letter on the CDC and FDA, September 4th, 2005
"We demonstrated that, despite extraction treatments that might be expected to inactivate this organism, M. tuberculosis remained viable during this process," wrote W. Somerville and colleagues at Montreal General Hospital.
The authors concluded, "These data suggest that the extraction of M. tuberculosis DNA should be performed within...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.